Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The crystal structures of the human androgen receptor (hAR) and human progesterone receptor ligand-binding domains in complex with the same ligand metribolone (R1881) have been determined. Both three-dimensional structures show the typical nuclear receptor fold. The change of two residues in the ligand-binding pocket between the human progesterone receptor and hAR is most likely the source for the specificity of R1881 to the hAR. The structural implications of the 14 known mutations in the ligand-binding pocket of the hAR ligand-binding domains associated with either prostate cancer or the partial or complete androgen receptor insensitivity syndrome were analyzed. The effects of most of these mutants could be explained on the basis of the crystal structure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The LBD and DBD X-ray crystal structures of AR have been solved separately (Matias et al., 2000; Sack et al., 2001; Shaffer et al., 2004).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Matias et al., 2000
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,578
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,953
Research works printed but not linked: 8
- Otwinowski, 1997, 276, 307
- Lamzin, 1997, 277, 269
- Kleywegt, 1995, Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography, 31, 45
- Bellis, 1992, Mol. Endocrinol., 6, 1909
- Pinsky, 1992, Clin. Invest. Med., 15, 456
- Lumbroso, 1996, J. Clin. Endocrinol. & Metab., 81, 1984
- Jakubicza, 1992, Hum. Genet., 90, 311
- Nakao, 1992, J. Clin. Endocrinol. & Metab., 74, 1152
Cited by
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
“Crystallographic studies of the ligand-binding domain of the wild-type A”
BackgroundMolecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Androgen receptor: structure, role in prostate cancer and drug discovery
Tan, M. E., Li, J., Xu, H. E., Melcher, K., & Yong, E.-L. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.18 · Cited by 943
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 942
Dehm, S. M., Schmidt, L. J., Heemers, H. V., Vessella, R. L., & Tindall, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0594 · Cited by 834
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds
Issa, F., Kassiou, M., & Rendina, L. M. (2011) · Chemical Reviews · doi:10.1021/cr2000866 · Cited by 759
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753
Comparative Study of the Endocrine-Disrupting Activity of Bisphenol A and 19 Related Compounds
Kitamura, S. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi074 · Cited by 743
Formation of the Androgen Receptor Transcription Complex
Shang, Y., Myers, M., & Brown, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00471-9 · Cited by 672
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568
Androgen insensitivity syndrome
Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V., Mastroyannopoulou, K., & MacDougall, J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60071-3 · Cited by 553
Structural Overview of the Nuclear Receptor Superfamily: Insights into Physiology and Therapeutics
Huang, P., Chandra, V., & Rastinejad, F. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135917 · Cited by 533
Chemistry and Structural Biology of Androgen Receptor
Gao, W., Bohl, C. E., & Dalton, J. T. (2005) · Chemical Reviews · doi:10.1021/cr020456u · Cited by 528
The androgen receptor gene mutations database: 2012 update
Gottlieb, B., Beitel, L. K., Nadarajah, A., Paliouras, M., & Trifiro, M. (2012) · Human Mutation · doi:10.1002/humu.22046 · Cited by 512
(2001) · PubMed · Cited by 500
Sack, J. S., Kish, K. F., Wang, C., Attar, R. M., Kiefer, S. E., An, Y., Wu, G. Y., Scheffler, J. E., Salvati, M. E., Krystek, S. R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081565498 · Cited by 491
Lu, N. Z., Wardell, S. E., Burnstein, K. L., Defranco, D., Fuller, P. J., Giguere, V., Hochberg, R. B., McKay, L., Renoir, J.-M., Weigel, N. L., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.9 · Cited by 426
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
Bohl, C. E., Gao, W., Miller, D. D., Bell, C. E., & Dalton, J. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500381102 · Cited by 421
Study of 202 Natural, Synthetic, and Environmental Chemicals for Binding to the Androgen Receptor
Fang, H., Tong, W., Branham, W. S., Moland, C. L., Dial, S. L., Hong, H., Xie, Q., Perkins, R., Owens, W., & Sheehan, D. M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx030011g · Cited by 398
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
Taplin, M., & Balk, S. P. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10653 · Cited by 390
Alternatively spliced androgen receptor variants
Dehm, S. M., & Tindall, D. J. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0141 · Cited by 380
Yuan, X., Cai, C., Chen, S., Chen, S., Yu, Z., & Balk, S. P. (2014) · Oncogene · doi:10.1038/onc.2013.235 · Cited by 370
Nuclear Receptor Structure: Implications for Function
Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D., & Miura, M. T. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160308 · Cited by 366
Taplin, M.-E., Rajeshkumar, B., Halabi, S., Werner, C. P., Woda, B. A., Picus, J., Stadler, W., Hayes, D. F., Kantoff, P. W., Vogelzang, N. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.102 · Cited by 364
Molecular basis of androgen insensitivity
Brinkmann, A. O. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00466-x · Cited by 348
Kauppi, B., Jakob, C., Färnegårdh, M., Yang, J., Ahola, H., Alarcon, M., Calles, K., Engström, O., Harlan, J., Muchmore, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212711200 · Cited by 336
Chen, Y., Clegg, N. J., & Scher, H. I. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70229-3 · Cited by 324
2.1 Å Crystal Structure of Human PXR in Complex with the St. John's Wort Compound Hyperforin,
Watkins, R. E., Maglich, J. M., Moore, L. B., Wisely, G. B., Noble, S. M., Davis-Searles, P. R., Lambert, M. H., Kliewer, S. A., & Redinbo, M. R. (2003) · Biochemistry · doi:10.1021/bi0268753 · Cited by 319
Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids
Wisely, G. B., Miller, A. B., Davis, R. G., Thornquest, A. D., Johnson, R., Spitzer, T., Sefler, A., Shearer, B., Moore, J. T., Miller, A. B., et al. (2002) · Structure · doi:10.1016/s0969-2126(02)00829-8 · Cited by 311
The androgen receptor gene mutations database (ARDB): 2004 update
Gottlieb, B., Beitel, L. K., Wu, J. H., & Trifiro, M. (2004) · Human Mutation · doi:10.1002/humu.20044 · Cited by 311
Alternative splicing in cancer: implications for biology and therapy
Chen, J., & Weiss, W. A. (2015) · Oncogene · doi:10.1038/onc.2013.570 · Cited by 304
He, B., Gampe, R. T., Kole, A. J., Hnat, A. T., Stanley, T. B., An, G., Stewart, E. L., Kalman, R. I., Minges, J. T., & Wilson, E. M. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.036 · Cited by 295
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects
di Masi, A., Marinis, E. D., Ascenzi, P., & Marino, M. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.002 · Cited by 288
Nuclear Receptors and Their Selective Pharmacologic Modulators
Burris, T. P., Solt, L. A., Wang, Y., Crumbley, C., Banerjee, S., Griffett, K., Lundasen, T., Hughes, T., & Kojetin, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006833 · Cited by 283
Pereira de Jésus‐Tran, K., Côté, P., Cantin, L., Blanchet, J., Labrie, F., & Breton, R. (2006) · Protein Science · doi:10.1110/ps.051905906 · Cited by 278
Jung, M. E., Ouk, S., Yoo, D., Sawyers, C. L., Chen, C., Tran, C., & Wongvipat, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901488g · Cited by 266
Chmelar, R., Buchanan, G., Need, E. F., Tilley, W., & Greenberg, N. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22365 · Cited by 255
Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate Cancer
Dehm, S. M., & Tindall, D. J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0223 · Cited by 253
Androgen receptors in prostate cancer.
Culig, Z., Klocker, H., Bartsch, G., & Hobisch, A. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090155 · Cited by 247
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
de Souza Neto, L. R., Moreira-Filho, J. T., Neves, B. J., Maidana, R. L. B. R., Guimarães, A. C. R., Furnham, N., Andrade, C. H., & Silva, F. P. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00093 · Cited by 240
Recognition and Accommodation at the Androgen Receptor Coactivator Binding Interface
Hur, E., Pfaff, S. J., Payne, E. S., Grøn, H., Buehrer, B. M., & Fletterick, R. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020274 · Cited by 234
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
Claessens, F., Denayer, S., Van Tilborgh, N., Kerkhofs, S., Helsen, C., & Haelens, A. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06008 · Cited by 231
Structural Features of Tight-Junction Proteins
Heinemann, U., & Schuetz, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236020 · Cited by 231
Lavery, D. N., & Mcewan, I. J. (2005) · Biochemical Journal · doi:10.1042/bj20050872 · Cited by 227
Collocation of androgen receptor gene mutations in prostate cancer.
Buchanan, G., Greenberg, N. M., Scher, H. I., Harris, J. M., Marshall, V. R., & Tilley, W. D. (2001) · PubMed · Cited by 227
Structural and functional consequences of glutamine tract variation in the androgen receptor
Buchanan, G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh181 · Cited by 225
Coactivator Binding Promotes the Specific Interaction Between Ligand and the Pregnane X Receptor
Watkins, R. E., Davis-Searles, P. R., Lambert, M. H., & Redinbo, M. R. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00795-2 · Cited by 220
Bledsoe, R. K., Madauss, K. P., Holt, J. A., Apolito, C. J., Lambert, M. H., Pearce, K. H., Stanley, T. B., Stewart, E. L., Trump, R. P., Willson, T. M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504098200 · Cited by 218
Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)
Gao, W., & Dalton, J. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.003 · Cited by 215
Structural Basis for Accommodation of Nonsteroidal Ligands in the Androgen Receptor
Bohl, C. E., Miller, D. D., Chen, J., Bell, C. E., & Dalton, J. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507464200 · Cited by 210
Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone
Askew, E. B., Gampe, R. T., Stanley, T. B., Faggart, J. L., & Wilson, E. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703268200 · Cited by 210
Mohler, M. L., Bohl, C. E., Jones, A., Coss, C. C., Narayanan, R., He, Y., Hwang, D. J., Dalton, J. T., & Miller, D. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900280m · Cited by 205
Clark, D. E., Errington, T. M., Smith, J. A., Frierson, H. F., Weber, M. J., & Lannigan, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3151 · Cited by 200
Minireview: Sex Differentiation
Hughes, I. A. (2001) · Endocrinology · doi:10.1210/en.142.8.3281 · Cited by 197
Structure of the homodimeric androgen receptor ligand-binding domain
Nadal, M., Prekovic, S., Gallastegui, N., Helsen, C., Abella, M., Zielinska, K., Gay, M., Vilaseca, M., Taulès, M., Houtsmuller, A. B., et al. (2017) · Nature Communications · doi:10.1038/ncomms14388 · Cited by 193
Byrne, C., Divekar, S. D., Storchan, G. B., Parodi, D. A., & Martin, M. B. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.025 · Cited by 193
Mutation of the androgen receptor causes oncogenic transformation of the prostate.
Han, G., Buchanan, G., Ittmann, M., Harris, J. M., Yu, X., DeMayo, F. J., Tilley, W., & Greenberg, N. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408925102 · Cited by 192
The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators
He, B., Minges, J. T., Lee, L. W., & Wilson, E. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111975200 · Cited by 189
Melo, K. F. S., Mendonca, B. B., Billerbeck, A. E. C., Costa, E. M. F., Inácio, M., Silva, F. A. Q., Leal, A. M. O., Latronico, A. C., & Arnhold, I. J. P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021658 · Cited by 189
Li, Y., Suino, K., Daugherty, J., & Xu, H. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.026 · Cited by 187
Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT
Liao, G., Chen, L.-Y., Zhang, A., Godavarthy, A., Xia, F., Ghosh, J. C., Li, H., & Chen, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206374200 · Cited by 183
Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication
Lee, D. K., & Chang, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030261 · Cited by 183
Mechanism of androgen receptor action
Li, J., & Al-Azzawi, F. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.03.008 · Cited by 183
Plant-derived 3,3′-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells
Le, H. T., Schaldach, C. M., Firestone, G. L., & Bjeldanes, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300588200 · Cited by 182
The role of androgen receptor mutations in prostate cancer progression.
Brooke, G., & Bevan, C. (2009) · Current Genomics · doi:10.2174/138920209787581307 · Cited by 181
Nuclear Hormone Receptor Targeted Virtual Screening
Schapira, M., Abagyan, R., & Totrov, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0300173 · Cited by 180
New aspects of cadmium as endocrine disruptor.
瀧口, 益., & Yoshihara, S. (2006) · PubMed · Cited by 178
Gobinet, J., Poujol, N., & Sultan, C. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00364-7 · Cited by 172
Fu, M., Wang, C., Wang, J., Zhang, X., Sakamaki, T., Yeung, Y. G., Chang, C., Hopp, T., Fuqua, S. A. W., Jaffray, E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3373-3388.2002 · Cited by 171
Song, L.-N., Herrell, R., Byers, S., Shah, S., Wilson, E. M., & Gelmann, E. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1674-1687.2003 · Cited by 169
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer
Cato, L., de Tribolet-Hardy, J., Lee, I., Rottenberg, J. T., Coleman, I., Melchers, D., Houtman, R., Xiao, T., Li, W., Uo, T., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.008 · Cited by 167
Identification and Characterization of a Ligand-regulated Nuclear Export Signal in Androgen Receptor
Saporita, A. J., Zhang, Q., Navai, N., Dincer, Z., Hahn, J., Cai, X., & Wang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302460200 · Cited by 167
Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
Buchanan, G., Irvine, R. A., Coetzee, G. A., & Tilley, W. D. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015531326689 · Cited by 165
Fragkaki, A. G., Angelis, Y. S., Koupparis, M. Α., Tsantili‐Kakoulidou, A., Kokotos, G., & Georgakopoulos, C. G. (2008) · Steroids · doi:10.1016/j.steroids.2008.10.016 · Cited by 165
Crystallization of protein–ligand complexes
Hassell, A. M., An, G., Bledsoe, R. K., Bynum, J. M., Carter, H. L., Deng, S.-J. J., Gampe, R. T., Grisard, T. E., Madauss, K. P., Nolte, R. T., et al. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906047020 · Cited by 165
Estébanez-Perpiñá, E., Moore, J. M. R., Mar, E., Delgado-Rodrigues, E., Nguyen, P., Baxter, J. D., Buehrer, B. M., Webb, P., Fletterick, R. J., & Guy, R. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407046200 · Cited by 164
Androgen insensitivity syndrome: clinical features and molecular defects
Galani, A., Kitsiou-Tzeli, S., Sofokleous, C., Kanavakis, E., & Kalpini-Mavrou, A. (2008) · Hormones · doi:10.14310/horm.2002.1201 · Cited by 162
The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer
Chatterjee, B. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026057402945 · Cited by 162
Hughes, I. A., & Deeb, A. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.11.003 · Cited by 159
Phenotypic heterogeneity of mutations in androgen receptor gene
Singh, R., Singh, L., & Thangaraj, K. (2007) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2007.00250.x · Cited by 159
Xin, L., Teitell, M. A., Lawson, D. A., Kwon, A., Mellinghoff, I. K., & Witte, O. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602567103 · Cited by 158
Selective androgen receptor modulators in preclinical and clinical development
Narayanan, R., Mohler, M. L., Bohl, C. E., Miller, D. D., & Dalton, J. T. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06010 · Cited by 158
McEwan, I. J. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110281 · Cited by 156
Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes
Yu, X., Yi, P., Hamilton, R. A., Shen, H., Chen, M., Foulds, C. E., Mancini, M. A., Ludtke, S. J., Wang, Z., & O’Malley, B. W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.031 · Cited by 154
Androgen receptor gene and male infertility
Yong, E., Loy, C. J., & Sim, K. S. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg003 · Cited by 153
The Nuclear Receptor Superfamily and Drug Discovery
Moore, J. T., Collins, J. L., & Pearce, K. H. (2006) · ChemMedChem · doi:10.1002/cmdc.200600006 · Cited by 150
Verrijdt, G. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00003-9 · Cited by 148
Centenera, M. M., Harris, J. M., Tilley, W. D., & Butler, L. M. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0017 · Cited by 145
Inhibition of Androgen Receptor (AR) Function by the Reproductive Orphan Nuclear Receptor DAX-1
Holter, E. (2002) · Molecular Endocrinology · doi:10.1210/me.16.3.515 · Cited by 144
Conformational Analysis of the Androgen Receptor Amino-terminal Domain Involved in Transactivation
Reid, J., Kelly, S. M., Watt, K., Price, N. C., & McEwan, I. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201003200 · Cited by 143
Stepwise androgen receptor dimerization
van Royen, M. E., van Cappellen, W. A., de Vos, C., Houtsmuller, A. B., & Trapman, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.096792 · Cited by 143
Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension
Fagart, J., Huyet, J., Pinon, G. M., Rochel, M., Mayer, C., & Rafestin-Oblin, M. E. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb939 · Cited by 142
Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1
Chauchereau, A., Amazit, L., Quesne, M., Guiochon-Mantel, A., & Milgrom, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207148200 · Cited by 142
He, B., Bowen, N. T., Minges, J. T., & Wilson, E. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107492200 · Cited by 140
Role of Cadmium in the Regulation of AR Gene Expression and Activity
Martin, M. B., Voeller, H. J., Gelmann, E. P., Lü, J., Stoica, E.-G., Hebert, E. J., Reiter, R., Singh, B., Danielsen, M., Pentecost, E., et al. (2002) · Endocrinology · doi:10.1210/endo.143.1.8581 · Cited by 140
Steketee, K., Timmerman, L., Ziel‐van der Made, A. C. J., Doesburg, P., Brinkmann, A. O., & Trapman, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10495 · Cited by 139
Androgen Receptor: Structural Domains and Functional Dynamics after Ligand‐Receptor Interaction
ROY, A. K., TYAGI, R. K., SONG, C. S., LAVROVSKY, Y., AHN, S. C., OH, T., & CHATTERJEE, B. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb04001.x · Cited by 133
Metadata
- Authors
- Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., Bäsler, S., Schäfer, M., Egner, U., & Carrondo, M. A.
- Affiliations
- Universidade Nova de Lisboa (PT)
- Instituto de Biologia Experimental e Tecnológica (PT)
- Corresponding author
- Carrondo, Maria Arménia
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 34
- Pages
- 26164-26171
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2151922331
- Cited by
- 608
- References
- 53
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 14 · 2023: 20 · 2022: 17 · 2021: 12 · 2020: 18 · 2019: 11 · 2018: 13 · 2017: 14 · 2016: 16 · 2015: 23 · 2014: 12 · 2013: 22 · 2012: 17
- FWCI
- 37.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7373 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- androgen receptor, ligand-binding domain, ligand specificity, progesterone receptor, binding pocket, point mutations, prostate cancer, crystal structure
- MeSH terms
- Amino Acid Sequence, Binding Sites, Humans, Ligands, Male, Models, Chemical, Models, Molecular, Molecular Conformation, Molecular Sequence Data, Prostatic Neoplasms, Protein Conformation, Receptors, Androgen, Metribolone, Mutagenesis, Site-Directed, Crystallography, X-Ray, Amino Acid Substitution, Testosterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.